Schiff Nutrition International Inc.  

(Public, NYSE:SHF)   Watch this stock  
Find more results for SHF
18.01
+0.53 (3.03%)
Real-time:   12:07PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 17.06 - 18.24
52 week 8.68 - 19.15
Open 17.41
Vol / Avg. 21,823.00/44,641.00
Mkt cap 526.74M
P/E 38.62
Div/yield     -
EPS 0.47
Shares 29.25M
Beta 0.71
Inst. own 61%
Jul 31, 2012
Q4 2012 Schiff Nutrition International Earnings Conference Call
Jul 31, 2012
Q4 2012 Schiff Nutrition International, Inc. Earnings Release
Jun 6, 2012
Schiff Nutrition International, Inc. at Jefferies Global Healthcare Conference
May 16, 2012
Schiff Nutrition International, Inc. at Bank of America Merrill Lynch Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (May '12) 2012
Net profit margin 2.90% 5.30%
Operating margin 9.41% 9.83%
EBITD margin - 12.12%
Return on average assets 3.25% 5.91%
Return on average equity 7.04% 13.10%
Employees 414 -
Carbon Disclosure Rating - -

Address

2002 South 5070 West
SALT LAKE CITY, UT 84104-4726
United States - Map
+1-801-9755000 (Phone)
+1-801-9722223 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United States and throughout the world. The Company offers a range of capsules, tablets and nutrition bars. Its portfolio of recognized brands, including Schiff Move Free,Schiff, Vitamins, Schiff MegaRed, Schiff Mega-D3, Tiger�s Milk, Schiff Sustenex, and Schiff Digestive Advantage is marketed through the mass market (including club) and health food store distribution channels. The Company markets a line of specialty supplements, vitamins and minerals under the Schiff brand. The Schiff brand includes ingredients, primarily consisting of tablet, capsule and softgel product forms.

Officers and directors

Eric Weider Chairman of the Board
Age: 48
Bio & Compensation - Reuters
Tarang P. Amin President, Chief Executive Officer, Director
Age: 46
Bio & Compensation - Reuters
George F. Lengvari Vice Chairman of the Board
Age: 69
Bio & Compensation - Reuters
Joseph W. Baty Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation - Reuters
Jennifer Steeves-Kiss Senior Vice President, Chief Marketing Officer
Age: 39
Bio & Compensation - Reuters
Scott K. Milsten Senior Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation - Reuters
Richard F. Baruch Jr. Senior Vice President, Chief Commercial Officer
Age: 44
Bio & Compensation - Reuters
Shane Durkee Senior Vice President - Research and Development
Age: 39
Bio & Compensation - Reuters
Jon Fieldman Senior Vice President - Operations
Age: 41
Bio & Compensation - Reuters
Roger H. Kimmel Director
Age: 65
Bio & Compensation - Reuters